[Form 4] Parker-Hannifin Corporation Insider Trading Activity

Rhea-AI Filing Summary

Jennifer A. Parmentier, Director and Chief Executive Officer of Parker-Hannifin Corporation (PH), received an award of Stock Appreciation Rights (SARs) on 08/20/2025. The Form 4 reports the grant of 28,483 SARs with a grant price/conversion reference of $742.97. The SARs were acquired (reported as an award) on 08/20/2025, become exercisable in part beginning 08/20/2026, and expire 08/19/2035. The filing states the award vests in three equal annual installments beginning 08/20/2026. After the grant, the report shows beneficial ownership of 28,483 underlying shares attributable to these SARs on a direct basis. The Form 4 was signed by an attorney-in-fact on 08/22/2025.

Positive

• Executive alignment with shareholders: CEO granted 28,483 SARs, linking compensation to stock performance
• Multi-year vesting: Award vests in three equal annual installments, supporting retention through 2028

Negative

• Potential dilution: SARs underlie 28,483 common shares, which could increase share count if settled in stock
• Financial impact unspecified: Form 4 does not disclose expense or valuation assumptions for the award

Insights

Financial Analyst

TL;DR: CEO awarded 28,483 SARs vesting over three years; represents executive equity-linked compensation with potential dilution if settled in stock.

The reported award of 28,483 Stock Appreciation Rights to the CEO ties future payout to Parker-Hannifin's stock performance, aligning management incentives with shareholder value creation. The SARs have a reference price of $742.97 and a long expiration to 08/19/2035, providing a multi-year performance horizon. Vesting in three equal annual installments beginning 08/20/2026 spaces dilution and retention effects over multiple years. The immediate accounting or expense impact is not stated in the Form 4 and cannot be inferred from this filing alone.

Corporate Governance Expert

TL;DR: Grant appears to be a standard executive equity award with multi-year vesting; disclosure is routine under Section 16 rules.

The Form 4 discloses a non-derivative economic award (SARs) to the CEO who is also a director, filed as required. Vesting in three equal annual installments beginning one year after grant is typical for retention-focused compensation. The filing is complete in reporting the award amount, exercise/settlement timeline and expiration date; it was executed by an attorney-in-fact and signed on 08/22/2025. No governance concerns or departures from standard disclosure practice are evident from the provided content alone.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Parmentier Jennifer A

(Last) (First) (Middle)

6035 PARKLAND BOULEVARD

(Street)

CLEVELAND OH 44124

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Parker-Hannifin Corp [ PH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Rights	$742.97	08/20/2025		A		28,483		08/20/2026(1)	08/19/2035	Common Stock	28,483	$0	28,483	D

Explanation of Responses:

1. The Stock Appreciation Rights award vests in three equal annual installments beginning 8/20/26.

	/s/Stephanie R. Breitenbach, Attorney-in-Fact	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 filed for PH disclose?

The filing discloses an award of 28,483 Stock Appreciation Rights (SARs) to Jennifer A. Parmentier on 08/20/2025.

When do the SARs vest and when do they expire?

The SARs vest in three equal annual installments beginning 08/20/2026 and expire on 08/19/2035.

What is the reference price associated with the SARs?

The SARs are reported with a reference amount of $742.97 in the filing.

How many underlying shares are associated with the SARs?

The award underlies 28,483 shares of Common Stock, and the Form 4 shows 28,483 beneficially owned following the transaction.

Who reported the transaction and what is her role at PH?

The reporting person is Jennifer A. Parmentier, identified as a Director and Chief Executive Officer of Parker-Hannifin Corporation.

When was the Form 4 signed and filed?

The Form 4 bears a signature by an attorney-in-fact on 08/22/2025.